How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: Systematic review

British Medical Journal

Volumn 330, Issue 7492, 2005, Pages 625-627

  Doust, Jenny A ^a   Pietrzak, Eva ^a   Dobson, Annette ^a   Glasziou, Paul P ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b Centre for Evidence Based Medicine   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER;

EMBASE; HEART DEATH; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MEDLINE; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; REVIEW; RISK; STATISTICAL ANALYSIS; SUDDEN DEATH; SYSTEMATIC REVIEW; BLOOD; CARDIOVASCULAR DISEASE; CONGESTIVE HEART FAILURE; MORTALITY; PREDICTION AND FORECASTING; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SURVIVAL;

BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; DEATH, SUDDEN, CARDIAC; HEART FAILURE, CONGESTIVE; HUMANS; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 15944365796     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.330.7492.625     Document Type: Review

References (9)

1. Bouvy ML, Heerdink ER, Leufkens HG, Hoes AW. Predicting mortality in patients with heart failure: a pragmatic approach. Heart 2003;89:605-9.
2. Cowie MR, Wood DA, Coats AJ, Thompson SG, Suresh V, Poole-Wilson PA, et al. Survival of patients with a new diagnosis of heart failure: a population based study. Heart 2000;83:505-10.
3. Scrutinio D, Lagioia R, Ricci A, Clemente M, Boni L, Rizzon P. Prediction of mortality in mild to moderately symptomatic patients with left ventricular dysfunction. The role of the New York Heart Association classification, cardiopulmonary exercise testing, two-dimensional echocardiography and Holter monitoring. Eur Heart J 1994;15:1089-95.
4. Aaronson KD, Schwartz JS, Chen TM, Wong KL, Goin JE, Mancini DM. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation 1997;95:2660-7.
5. Doust JA, Glasziou PP, Pietrzak E, Dobson AJ. A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure. Arch Intern Med 2004;164:1978-84.
6. Altman DG. Systematic reviews of evaluations of prognostic variables. BMJ 2001;323:224-8.
7. Jessup M, Brozena S. Heart failure. N Engl J Med 2003;348:2007-18.
8. Murdoch DR, McDonagh TA, Byrne J, Blue L, Farmer R, Morton JJ, et al. Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy. Am Heart J 1999;138(6 Pt 1):1126-32.
9. Troughton RW, Frampton CM, Yandle TG, Espiner EA, Nicholls MG, Richards AM. Treatment of heart failure guided by plasma amino-terminal brain natriuretic peptide (N-BNP) concentrations. Lancet 2000;355:1126-30.